Ocugen to Present Gene Therapy Data at July Conferences
MALVERN, PA — Ocugen (NASDAQ: OCGN) will present updates on its modifier gene therapy platform and clinical data from its retinal disease programs at a series of investor and industry …
Ocugen to Present Gene Therapy Data at July Conferences Read More